Effect of Dapagliflozin on Total Heart Failure Events in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial
Pardeep S. Jhund, Brian L. Claggett, Atefeh Talebi, Jawad H. Butt, Samvel B. Gasparyan, Lee Jen Wei, Zachary R. McCaw, Ulrica Wilderäng, Olof Bengtsson, Akshay S. Desai, Magnus Petersson, Anna Maria Langkilde, Rudolf A. De Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Carolyn S.P. Lam, Felipe A. Martinez, Sanjiv J. Shah, Muthiah VaduganathanScott D. Solomon, John J.V. McMurray
Dive into the research topics of 'Effect of Dapagliflozin on Total Heart Failure Events in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial'. Together they form a unique fingerprint.